Table III.
Distribution of analyzed molecules by the rDD groups
| Variable | rDD patients treated with SSRI n = 39 |
rDD patients treated with other antidepressants n = 34 |
Statistical analysis P-value2 |
|---|---|---|---|
| IL-18 [pg/ml] | 272.43 (180.35–328.42)1 | 351.53 (218.21–418.75) | 0.064 |
| TGF-β [pg/ml] | 196.7 (172.3–273.4) | 199.3 (184.9–283.10) | 0.45 |
| RANTES [ng/ml] | 92.78 (84.35–113.56) | 66.66 (60.71–72.03) | < 0.0001 |
| ICAM-1 [ng/ml] | 265.48 (197.56–342.67) | 266.56 (230.68–345.22) | 0.53 |
| suPAR [ng/ml] | 2.44 (2.19–3.03) | 2.3 (2.14–2.78) | 0.36 |
rDD – recurrent depressive disorder, IL-interleukin, TGF – transforming growth factor, ICAM-intercellular adhesion molecule, uPAR – urokinase plasminogen activator receptor, SSRI – selective seroonine reuptake inhibitors,
1
median (the firs quartile Q1, the third quartile Q3),
2
U-Mann Whitney test.